Engelbert Catherine M.
SEC insider (Form 3/4/5 filer). CIK 0001796439. Director at Royalty Pharma plc (RPRX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in NEW YORK, NY.
Companies Engelbert Catherine M. has filed insider reports for
- Royalty Pharma plc (RPRX): Director
- MCDONALDS CORP (MCD): Director
Engelbert Catherine M.
CIK: 0001796439
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 5, 2026RPRX
Royalty Pharma plc
AwardDirect4.5K shares- - Dec 31, 2025MCD
MCDONALDS CORP
AwardDirectPhantom Stock
671 shares at avg. $305.63- - May 13, 2025RPRX
Royalty Pharma plc
AwardDirect7.6K shares- - Dec 31, 2024MCD
MCDONALDS CORP
AwardDirectPhantom Stock
700 shares at avg. $289.89-
1-4 of 4 transactions